U.S. Markets close in 5 hrs 3 mins
  • S&P 500

    3,690.45
    +23.73 (+0.65%)
     
  • Dow 30

    30,135.06
    +165.54 (+0.55%)
     
  • Nasdaq

    12,425.11
    +47.93 (+0.39%)
     
  • Russell 2000

    1,872.37
    +23.67 (+1.28%)
     
  • Crude Oil

    46.05
    +0.41 (+0.90%)
     
  • Gold

    1,837.80
    -3.30 (-0.18%)
     
  • Silver

    24.15
    +0.06 (+0.26%)
     
  • EUR/USD

    1.2142
    -0.0007 (-0.0607%)
     
  • 10-Yr Bond

    0.9790
    +0.0590 (+6.41%)
     
  • Vix

    20.77
    -0.51 (-2.40%)
     
  • GBP/USD

    1.3473
    +0.0020 (+0.1482%)
     
  • USD/JPY

    104.2190
    +0.3590 (+0.3457%)
     
  • BTC-USD

    18,967.46
    -290.13 (-1.51%)
     
  • CMC Crypto 200

    372.14
    -7.10 (-1.87%)
     
  • FTSE 100

    6,558.50
    +68.23 (+1.05%)
     
  • Nikkei 225

    26,751.24
    -58.13 (-0.22%)
     

Reata Pharmaceuticals Inc (RETA) CEO James Warren Huff Sold $14.3 million of Shares

GuruFocus.com
·1 min read

- By insider

CEO of Reata Pharmaceuticals Inc (30-Year Financial, Insider Trades) James Warren Huff (insider trades) sold 81,657 shares of RETA on 11/10/2020 at an average price of $175.01 a share. The total sale was $14.3 million.


Reata Pharmaceuticals Inc is a clinical stage biopharmaceutical company engaged in identifying, developing, and commercializing product candidates to address rare and life-threatening diseases by targeting molecular pathways. Reata Pharmaceuticals Inc has a market cap of $6.13 billion; its shares were traded at around $180.97 with and P/S ratio of 698.72. GuruFocus has detected 2 severe warning signs with Reata Pharmaceuticals Inc. .

CEO Recent Trades:

  • CEO James Warren Huff sold 81,657 shares of RETA stock on 11/10/2020 at the average price of $175.01. The price of the stock has increased by 3.41% since.

Directors and Officers Recent Trades:

  • Chief Research Officer Colin John Meyer sold 25,000 shares of RETA stock on 11/09/2020 at the average price of $175. The price of the stock has increased by 3.41% since.

  • Director William D. Jr. Mcclellan sold 4,000 shares of RETA stock on 11/09/2020 at the average price of $150.01. The price of the stock has increased by 20.64% since.

  • Chief Commercial Officer Dawn Carter Bir sold 60,000 shares of RETA stock on 11/09/2020 at the average price of $162.51. The price of the stock has increased by 11.36% since.

For the complete insider trading history of RETA, click here

.This article first appeared on GuruFocus.